Loading...
XNYS
MED
Market cap119mUSD
Jul 10, Last price  
10.72USD
1D
0.09%
1Q
6.16%
Jan 2017
-74.35%
Name

Medifast Inc

Chart & Performance

D1W1MN
XNYS:MED chart
P/E
P/S
0.31
EPS
Div Yield, %
Shrs. gr., 5y
-1.51%
Rev. gr., 5y
-16.22%
Revenues
386m
-35.96%
74,086,00083,779,000105,445,000165,618,000257,552298,189,000356,706,000356,886,000285,285,000272,773,000274,534,000301,563,000501,003,000713,672,000934,842,0001,526,087,0001,598,577,0001,072,054,000602,463,000385,788,000
Net income
-19m
L
5,082,0003,837,0005,435,00011,963,00019,61118,541,00015,876,00023,969,00013,181,00020,058,00017,835,00027,721,00055,789,00077,916,000102,859,000164,031,000143,568,00099,415,0002,091,000-18,672,000
CFO
7m
-71.96%
5,845,0007,954,0005,496,00020,313,00028,769,00034,870,00040,264,00042,360,00025,536,00029,411,00025,350,00043,237,00060,816,00084,261,000145,196,00094,545,000194,570,000147,657,00024,476,0006,863,000
Dividend
Sep 18, 20231.65 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medifast, Inc., along with its subsidiary companies, specializes in the production and distribution of a diverse array of health and nutritional consumables. These offerings primarily focus on supporting weight loss, managing weight, and fostering overall healthy living across the United States and the Asia-Pacific region. The company's extensive product range encompasses nutritional bars, snack bites, pretzels, puffed snacks, cereals, various beverages, hearty meal alternatives, oatmeal, pancakes, puddings, soft-serve desserts, shakes, smoothies, baked goods, and soups. These items are prominently featured under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brand names. Sales of these products are facilitated through direct online transactions conducted via its e-commerce platform. Established in 1980, the firm maintains its corporate headquarters in Baltimore, Maryland.
IPO date
Dec 30, 1993
Employees
874
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT